Rubbing elbows in a unique Raleigh corporate incubator are founders of a firm with AI-powered genetic technology for hire, a startup that’s engineering plants to fight cattle burping, and a developer ...

DHAKA, Sept 26, 2025 (BSS) - Education Advisor Professor Dr. Chowdhury Rafiqul Abrar said today that the country has to adopt a biotechnology-driven approach to tackle pressing challenges in health, ...

A common bacterium was genetically engineered to eat a plastic-derived molecule and then digest it to produce the everyday painkiller, paracetamol. The microbe used by Stephen Wallace, professor of ...

You’re shopping for some milk, and there it is. A bottle of the white stuff in just the right shape for picking up and putting into your shopping cart.

For the first time, researchers at Umeå University have observed the same type of programmed cell death in microalgae as in humans. The discovery, published in Nature Communications, shows that this ...

The Korea Society for Biotechnology and Bioengineering-Asian Federation of Biotechnology joint conference (KSBB-AFOB 2025), which concluded in Incheon on the 26th, is regarded as an event that ...

Vetagro, an Italian company specializing in precision animal nutrition, has broken ground on its first full-scale U.S. manufacturing facility at Mistletoe Hall Commerce-Business Park in Easton. The ...

Believer Meats recently completed the first part of its regulatory requirements, receiving a No Questions Letter from the FDA confirming that its cultivation process, ingredients, and final product ...

Innovative agritech solutions, including vertical farming and AI, are reshaping agriculture, enhancing crop yields and sustainability for global food security.

Loopworm recently announced a Series A funding round to commercialize its proprietary recombinant protein platform, the LoopBac Protein Expression System, which uses gene-edited living silkworms, ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat genetic diseases.